Want to see NAMS full AI Analyst Report?
ETFs with NewAmsterdam Pharma Company (NAMS) Exposure
The following ETFs maintain exposure to NewAmsterdam Pharma Company (NAMS). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
40 ETFs Hold NewAmsterdam Pharma Company (NAMS)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in NAMS |
|---|---|---|---|---|---|---|
| DRKY | VistaShares Target 15 DRUKMacro Distribution ETF | $21.30M | 0.95% | 2.91% | $650.35K | 0.03% |
| SBIO | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | 1.60% | $2.94M | 0.12% |
| GURU | Global X Guru Index ETF | $58.75M | 0.75% | 1.07% | $636.71K | 0.03% |
| CAPG | Capital Group Global Equity Select ETF | $331.55M | 0.81% | 0.76% | $2.06M | 0.04% |
| FMED | Fidelity Disruptive Medicine ETF | $54.39M | 0.50% | 0.64% | $348.77K | 0.01% |
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | 0.51% | $176.31K | <0.01% |
| CGMM | Capital Group U.S. Small and Mid Cap ETF | $3.67B | 0.51% | 0.44% | $16.06M | 0.65% |
| CCUS | Counterpoint Global CIBC U.S. Small Cap Growth ETF Trust Units | $3.36M | ― | 0.32% | $10.63K | <0.01% |
| ACSG | American Century Small Cap Growth Insights ETF | $54.55M | 0.49% | 0.22% | $120.89K | <0.01% |
| XGEN | Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF Accum-1C- USD | $14.78M | 0.36% | 0.22% | $33.47K | <0.01% |
| ITIN | IA Clarington Thematic Innovation Class ETF Series Shares | $2.24M | ― | 0.21% | $224.65K | <0.01% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | 0.15% | $2.05M | 0.08% |
| PJSM | PGIM Jennison Small-Mid Cap Core Equity ETF | $6.04M | 0.29% | 0.15% | $10.07K | <0.01% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | 0.15% | $184.45K | <0.01% |
| IBB | iShares Biotechnology ETF | $11.52B | 0.44% | 0.11% | $12.11M | 0.50% |
| TNXT | T. Rowe Price Innovation Leaders ETF | $19.28M | 0.49% | 0.10% | $18.50K | <0.01% |
| FFSM | Fidelity Fundamental Small-Mid Cap ETF | $1.51B | 0.43% | 0.08% | $1.31M | 0.04% |
| STXK | Strive 2000 ETF | $79.32M | 0.18% | 0.08% | $67.03K | <0.01% |
| FFSM | Fidelity US Fundamental Small-Mid Cap UCITS ETF AccumUSD | ― | 0.50% | 0.08% | $16.62K | <0.01% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | $2.77B | 0.17% | 0.04% | $1.00M | 0.04% |
| VHT | Vanguard Health Care ETF | $20.70B | 0.09% | 0.02% | $4.78M | 0.16% |
| MSML | iShares MSCI USA Small-Cap ETF | $279.43M | 0.04% | 0.02% | $56.84K | <0.01% |
| CBUG | iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD | $484.34M | 0.38% | 0.02% | $92.67K | <0.01% |
| USSM | BNP Paribas Easy MSCI USA Small Cap Min Te UCITS ETF Accum-CAP- EUR | $30.68M | 0.30% | 0.02% | $15.60K | <0.01% |
| USSM | BNP Paribas Easy MSCI USA Small Cap Min Te UCITS ETF AccumUSD | $47.20M | 0.31% | 0.02% | $15.60K | <0.01% |
| FHLC | Fidelity MSCI Health Care Index ETF | $3.95B | 0.08% | 0.02% | $679.16K | 0.03% |
| WRDSC | UBS (Irl) ETF PLC - UBS MSCI World Small Cap UCITS ETF | $46.10M | 0.23% | 0.02% | $7,216 | <0.01% |
| WMSC | Amundi MSCI World Small Cap ESG Broad Transition UCITS ETF Accum USD | $550.73M | 0.27% | 0.01% | $74.74K | <0.01% |
| XSWD | Xtrackers MSCI World Small Cap UCITS ETF -1D- USD | $17.11M | 0.25% | 0.01% | $22.36K | <0.01% |
| XSWC | Xtrackers MSCI World Small Cap UCITS ETF Accum-1C- USD | $157.24M | 0.25% | 0.01% | $22.36K | <0.01% |
| WDSC | SSga II Wrd Sma Accum.Shs USD | $1.69B | 0.46% | 0.01% | $205.52K | <0.01% |
| WSCD | SPDR MSCI World Small Cap UCITS ETF USD | $52.03M | 0.46% | 0.01% | $205.52K | <0.01% |
| WSML | iShares MSCI World Small-Cap ETF | $668.76M | 0.30% | 0.01% | $75.65K | <0.01% |
| ONEQ | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | <0.01% | $724.03K | 0.03% |
| UEQE | UBS (Irl) ETF Plc - MSCI USA Select Factor Mix UCITS ETF | $32.83M | 0.25% | <0.01% | $8,794.5 | <0.01% |
| 0Y4T | UBS (Irl) ETF Plc - MSCI USA Select Factor Mix UCITS ETF | $8.49M | 0.28% | <0.01% | $8,794.5 | <0.01% |
| 0Y4V | UBS (Irl) ETF PLC - MSCI USA Select Factor Mix UCITS ETF Accum A Hedged CHF | $23.00M | 0.28% | <0.01% | $8,794.5 | <0.01% |
| USFMA | UBS (Irl) ETF Plc - MSCI USA Select Factor Mix UCITS ETF | $127.43M | 0.26% | <0.01% | $8,794.5 | <0.01% |
| GERD | L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD | $1.68B | 0.45% | <0.01% | $18.56K | <0.01% |
| K0MR | L&G Gerd Kommer Multifactor Equity UCITS ETF USD | $276.76M | 0.45% | <0.01% | $18.56K | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in NAMS |
|---|---|---|---|---|---|---|
| DRKY | 2.91% | VistaShares Target 15 DRUKMacro Distribution ETF | $21.30M | 0.95% | $650.35K | 0.03% |
| SBIO | 1.60% | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | $2.94M | 0.12% |
| GURU | 1.07% | Global X Guru Index ETF | $58.75M | 0.75% | $636.71K | 0.03% |
| CAPG | 0.76% | Capital Group Global Equity Select ETF | $331.55M | 0.81% | $2.06M | 0.04% |
| FMED | 0.64% | Fidelity Disruptive Medicine ETF | $54.39M | 0.50% | $348.77K | 0.01% |
| BBC | 0.51% | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | $176.31K | <0.01% |
| CGMM | 0.44% | Capital Group U.S. Small and Mid Cap ETF | $3.67B | 0.51% | $16.06M | 0.65% |
| CCUS | 0.32% | Counterpoint Global CIBC U.S. Small Cap Growth ETF Trust Units | $3.36M | ― | $10.63K | <0.01% |
| ACSG | 0.22% | American Century Small Cap Growth Insights ETF | $54.55M | 0.49% | $120.89K | <0.01% |
| XGEN | 0.22% | Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF Accum-1C- USD | $14.78M | 0.36% | $33.47K | <0.01% |
| ITIN | 0.21% | IA Clarington Thematic Innovation Class ETF Series Shares | $2.24M | ― | $224.65K | <0.01% |
| OM3E | 0.15% | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | $2.05M | 0.08% |
| PJSM | 0.15% | PGIM Jennison Small-Mid Cap Core Equity ETF | $6.04M | 0.29% | $10.07K | <0.01% |
| IBBQ | 0.15% | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | $184.45K | <0.01% |
| IBB | 0.11% | iShares Biotechnology ETF | $11.52B | 0.44% | $12.11M | 0.50% |
| TNXT | 0.10% | T. Rowe Price Innovation Leaders ETF | $19.28M | 0.49% | $18.50K | <0.01% |
| FFSM | 0.08% | Fidelity Fundamental Small-Mid Cap ETF | $1.51B | 0.43% | $1.31M | 0.04% |
| STXK | 0.08% | Strive 2000 ETF | $79.32M | 0.18% | $67.03K | <0.01% |
| FFSM | 0.08% | Fidelity US Fundamental Small-Mid Cap UCITS ETF AccumUSD | ― | 0.50% | $16.62K | <0.01% |
| ESML | 0.04% | iShares ESG Aware MSCI USA Small-Cap ETF | $2.77B | 0.17% | $1.00M | 0.04% |
| VHT | 0.02% | Vanguard Health Care ETF | $20.70B | 0.09% | $4.78M | 0.16% |
| MSML | 0.02% | iShares MSCI USA Small-Cap ETF | $279.43M | 0.04% | $56.84K | <0.01% |
| CBUG | 0.02% | iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD | $484.34M | 0.38% | $92.67K | <0.01% |
| USSM | 0.02% | BNP Paribas Easy MSCI USA Small Cap Min Te UCITS ETF Accum-CAP- EUR | $30.68M | 0.30% | $15.60K | <0.01% |
| USSM | 0.02% | BNP Paribas Easy MSCI USA Small Cap Min Te UCITS ETF AccumUSD | $47.20M | 0.31% | $15.60K | <0.01% |
| FHLC | 0.02% | Fidelity MSCI Health Care Index ETF | $3.95B | 0.08% | $679.16K | 0.03% |
| WRDSC | 0.02% | UBS (Irl) ETF PLC - UBS MSCI World Small Cap UCITS ETF | $46.10M | 0.23% | $7,216 | <0.01% |
| WMSC | 0.01% | Amundi MSCI World Small Cap ESG Broad Transition UCITS ETF Accum USD | $550.73M | 0.27% | $74.74K | <0.01% |
| XSWD | 0.01% | Xtrackers MSCI World Small Cap UCITS ETF -1D- USD | $17.11M | 0.25% | $22.36K | <0.01% |
| XSWC | 0.01% | Xtrackers MSCI World Small Cap UCITS ETF Accum-1C- USD | $157.24M | 0.25% | $22.36K | <0.01% |
| WDSC | 0.01% | SSga II Wrd Sma Accum.Shs USD | $1.69B | 0.46% | $205.52K | <0.01% |
| WSCD | 0.01% | SPDR MSCI World Small Cap UCITS ETF USD | $52.03M | 0.46% | $205.52K | <0.01% |
| WSML | 0.01% | iShares MSCI World Small-Cap ETF | $668.76M | 0.30% | $75.65K | <0.01% |
| ONEQ | <0.01% | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | $724.03K | 0.03% |
| UEQE | <0.01% | UBS (Irl) ETF Plc - MSCI USA Select Factor Mix UCITS ETF | $32.83M | 0.25% | $8,794.5 | <0.01% |
| 0Y4T | <0.01% | UBS (Irl) ETF Plc - MSCI USA Select Factor Mix UCITS ETF | $8.49M | 0.28% | $8,794.5 | <0.01% |
| 0Y4V | <0.01% | UBS (Irl) ETF PLC - MSCI USA Select Factor Mix UCITS ETF Accum A Hedged CHF | $23.00M | 0.28% | $8,794.5 | <0.01% |
| USFMA | <0.01% | UBS (Irl) ETF Plc - MSCI USA Select Factor Mix UCITS ETF | $127.43M | 0.26% | $8,794.5 | <0.01% |
| GERD | <0.01% | L&G Gerd Kommer Multifactor Equity UCITS ETF AccumUSD | $1.68B | 0.45% | $18.56K | <0.01% |
| K0MR | <0.01% | L&G Gerd Kommer Multifactor Equity UCITS ETF USD | $276.76M | 0.45% | $18.56K | <0.01% |
Popular ETF Comparisons
NAMS ETF Exposure FAQ
What ETFs hold NewAmsterdam Pharma Company stock?
NewAmsterdam Pharma Company (NAMS) is currently held by 40 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to NAMS include Capital Group (CGMM), ALPS (SBIO) and Capital Group (TSE:CAPG).
Which ETF has the largest exposure to NAMS?
The ETF with the largest exposure to NAMS is Capital Group (CGMM), with approximately $16.06M in market value exposure.
How much NAMS stock is held by ETFs?
ETFs currently hold approximately $23.03M worth of NewAmsterdam Pharma Company (NAMS) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.